(upbeat electronic music)
-: To me, the next horizons we'll be seeing:
more work on genome editing.
I think this concept of base editors that may be able
to handle monogenic diseases in vivo
could be a huge game changer.
-: I try to have a lot of empathy for you
whenever we read about the various decisions
in the news, because I think it is very challenging
to have to, one, implement a law,
but then, in that frame, then following the science,
but then also keeping up with society.
It's a very difficult, challenging position that you're in.
-: Yeah, no, I appreciate that.
Thank you for noting that.
I mean it is an interesting place to be here where,
even though, for instance,
for heritable genetic modifications,
it's not something that we can do right now
in the United States.
We can't have an ostrich approach
and just put our heads in the sand
because at some point it could become possible again,
and if we don't understand the technology,
if we don't understand where things are,
that will put us at a disadvantage.
So, we do need to keep up with these things
as they move along.